Over 20 years of experience in leading biomedical research and business.


June 23, 2021

Osteoimmuno-oncology, a novel concept describing interactions in bone metastasis to guide development of novel therapies

OncoBone contributed to an invited review article to the special issue ‘Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities’ in the Journal ‘Cells’, published on June 17, 2021. The review article titled ‘Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis‘ describes the novel concept of osteoimmuno-oncology (OIO) for the first time. OIO highlights […]

Read more

May 28, 2021

Working with CROs – lessons to learn from the webinar

OncoBone co-presented in a webinar titled ‘Working with CROs – from selection to managing relationships’ hosted by Biocom on March 30, 2021. OncoBone’s talk covered CRO selection, and featured speakers from Inotiv and Aligos Therapeutics continued about partnerships between CROs and Sponsors. Below is a summary of the key aspects covered in the webinar. There […]

Read more

April 27, 2021

Upcoming webinar: Human Immune System Models in Metastasis Research

OncoBone and Taconic Biosciences will co-present in a webinar titled: ‘Utility of Human Immune System Mice in Metastasis Cancer Drug Development’ on May 4, 2021. Below is a short overview of what to expect from the webinar.

Read more

November 13, 2020

Experiences on virtual scientific events in 2020 and hopes for 2021

Due to COVID-19 pandemic, the year 2020 has been exceptional in many ways. One of the big drawbacks in biomedical research and business has been that all scientific events were transferred to virtual format. OncoBone representatives attended four virtual scientific events this year. In this blog post we summarize our experiences about them and present our hopes for events organized in 2021.

Read more

September 1, 2020

How is it like to start a business during COVID-19 crisis

OncoBone offers scientific expertise especially in the fields of oncology and bone diseases. In this blog we discuss and comment new scientific discoveries, new accomplishments in drug development and emerging technologies, and biomedical business -related issues.

Read more



If you are interested to learn more,
see our services or contact us directly. logo Science Exchange logo

    Copyright © 2021 OncoBone Ltd